- Home
- SPSC vs MRUS Comparison
SPSC vs MRUS Comparison
Compare SPSC & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPSC
- MRUS
- Stock Information
- Founded
- SPSC 1987
- MRUS 2003
- Country
- SPSC United States
- MRUS Netherlands
- Employees
- SPSC N/A
- MRUS N/A
- Industry
- SPSC EDP Services
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- SPSC Technology
- MRUS Health Care
- Exchange
- SPSC Nasdaq
- MRUS Nasdaq
- Market Cap
- SPSC 5.1B
- MRUS 5.1B
- IPO Year
- SPSC 2010
- MRUS 2016
- Fundamental
- Price
- SPSC $105.53
- MRUS $69.58
- Analyst Decision
- SPSC Buy
- MRUS Strong Buy
- Analyst Count
- SPSC 9
- MRUS 13
- Target Price
- SPSC $165.33
- MRUS $90.92
- AVG Volume (30 Days)
- SPSC 436.1K
- MRUS 551.1K
- Earning Date
- SPSC 10-23-2025
- MRUS 10-30-2025
- Dividend Yield
- SPSC N/A
- MRUS N/A
- EPS Growth
- SPSC 13.55
- MRUS N/A
- EPS
- SPSC 2.18
- MRUS N/A
- Revenue
- SPSC $703,542,000.00
- MRUS $56,228,000.00
- Revenue This Year
- SPSC $21.79
- MRUS $57.42
- Revenue Next Year
- SPSC $9.39
- MRUS $0.23
- P/E Ratio
- SPSC $49.08
- MRUS N/A
- Revenue Growth
- SPSC 20.51
- MRUS 59.77
- 52 Week Low
- SPSC $102.05
- MRUS $33.19
- 52 Week High
- SPSC $201.06
- MRUS $70.65
- Technical
- Relative Strength Index (RSI)
- SPSC 37.45
- MRUS 62.18
- Support Level
- SPSC $108.67
- MRUS $65.74
- Resistance Level
- SPSC $114.67
- MRUS $70.65
- Average True Range (ATR)
- SPSC 3.38
- MRUS 2.41
- MACD
- SPSC 0.53
- MRUS 0.10
- Stochastic Oscillator
- SPSC 1.13
- MRUS 86.40
About SPSC SPS Commerce Inc.
SPS Commerce Inc is a provider of cloud-based supply chain management services for retailers, grocers, distributors, suppliers, and logistics firms to increase supply chain performance, optimize inventory levels and sell-through, reduce operational costs, improve order visibility, and satisfy consumer demands for a seamless omnichannel experience. Its solutions are delivered through the SPS Commerce platform and provide integrations and retail performance analytics to its customers. Its products are; Fulfillment, Analytics, and Other products like Assortment and Community also it provides one-time services such as professional services and testing and certification. The group derives revenue from subscription-based recurring revenue services.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.